Study shows magnesium sulfate reduces risk of cerebral palsy and death for very preterm babies

An international research collaboration conducting a comprehensive review of studies from across the globe has reaffirmed that magnesium sulfate, a medication widely used during pregnancy, significantly reduces the risk of cerebral palsy and death for very preterm babies.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup